Diagnamed Holdings (XCNQ:DMED) Total Current Assets : C$0.16 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Diagnamed Holdings's total current assets for the quarter that ended in Dec. 2024 was C$0.16 Mil.

Diagnamed Holdings Total Current Assets Historical Data

The historical data trend for Diagnamed Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings Total Current Assets Chart

Diagnamed Holdings Annual Data

Trend

Sep21

Sep22

Sep23

Sep24

Total Current Assets

2.39

1.62

0.66

0.20

Diagnamed Holdings Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Current Assets	Get a 7-Day Free Trial									0.55	0.40	0.20	0.20	0.16

Diagnamed Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Diagnamed Holdings's Total Current Assets for the fiscal year that ended in Sep. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.162	+	0.032	+	0	+	0.008
	=	0.20

Diagnamed Holdings's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.114	+	0.046	+	0	+	0.004
	=	0.16

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Diagnamed Holdings (XCNQ:DMED) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Diagnamed Holdings's Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.114	-	0.457	+	0.75 * 0.046	+	0.5 * 0
=	-0.31

Diagnamed Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnamed Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

DGNMF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.diagnamed.com

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

Executives

Fabio Chianelli

Director, Senior Officer

Diagnamed Holdings Headlines

No Headlines